Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity

<p><em>Plasmodium vivax</em>&nbsp;is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease.&nbsp;<e...

Full description

Bibliographic Details
Main Authors: Park, J-H, Kim, M-H, Sutanto, E, Na, S-W, Kim, M-J, Yeom, JS, Nyunt, MH, Abbas Elfaki, MM, Abdel Hamid, MM, Cha, SH, Alemu, SG, Sriprawat, K, Anstey, NM, Grigg, MJ, Barber, BE, William, T, Gao, Q, Liu, Y, Pearson, RD, Price, RN, Nosten, F, Yoon, S-I, No, JH, Han, E-T, Auburn, S, Russell, B, Han, J
Format: Journal article
Language:English
Published: Public Library of Science 2022
_version_ 1797107882124115968
author Park, J-H
Kim, M-H
Sutanto, E
Na, S-W
Kim, M-J
Yeom, JS
Nyunt, MH
Abbas Elfaki, MM
Abdel Hamid, MM
Cha, SH
Alemu, SG
Sriprawat, K
Anstey, NM
Grigg, MJ
Barber, BE
William, T
Gao, Q
Liu, Y
Pearson, RD
Price, RN
Nosten, F
Yoon, S-I
No, JH
Han, E-T
Auburn, S
Russell, B
Han, J
author_facet Park, J-H
Kim, M-H
Sutanto, E
Na, S-W
Kim, M-J
Yeom, JS
Nyunt, MH
Abbas Elfaki, MM
Abdel Hamid, MM
Cha, SH
Alemu, SG
Sriprawat, K
Anstey, NM
Grigg, MJ
Barber, BE
William, T
Gao, Q
Liu, Y
Pearson, RD
Price, RN
Nosten, F
Yoon, S-I
No, JH
Han, E-T
Auburn, S
Russell, B
Han, J
author_sort Park, J-H
collection OXFORD
description <p><em>Plasmodium vivax</em>&nbsp;is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease.&nbsp;<em>P</em>.&nbsp;<em>vivax</em>&nbsp;reticulocyte binding protein 1a (PvRBP1a) is a potential vaccine candidate, which is involved in red cell tropism, a crucial step in the merozoite invasion of host reticulocytes. As part of the initial evaluation of the PvRBP1a vaccine candidate, we investigated its genetic diversity and antigenicity using geographically diverse clinical isolates. We analysed&nbsp;<em>pvrbp1a</em>&nbsp;genetic polymorphisms using 202 vivax clinical isolates from six countries.&nbsp;<em>Pvrbp1a</em>&nbsp;was separated into six regions based on specific domain features, sequence conserved/polymorphic regions, and the reticulocyte binding like (RBL) domains. In the fragmented gene sequence analysis, PvRBP1a region II (RII) and RIII (head and tail structure homolog, 152&ndash;625 aa.) showed extensive polymorphism caused by random point mutations. The haplotype network of these polymorphic regions was classified into three clusters that converged to independent populations. Antigenicity screening was performed using recombinant proteins PvRBP1a-N (157&ndash;560 aa.) and PvRBP1a-C (606&ndash;962 aa.), which contained head and tail structure region and sequence conserved region, respectively. Sensitivity against PvRBP1a-N (46.7%) was higher than PvRBP1a-C (17.8%). PvRBP1a-N was reported as a reticulocyte binding domain and this study identified a linear epitope with moderate antigenicity, thus an attractive domain for merozoite invasion-blocking vaccine development. However, our study highlights that a global PvRBP1a-based vaccine design needs to overcome several difficulties due to three distinct genotypes and low antigenicity levels.</p>
first_indexed 2024-03-07T07:20:23Z
format Journal article
id oxford-uuid:d1146268-a898-49d1-8a7b-a441b67e31d0
institution University of Oxford
language English
last_indexed 2024-03-07T07:20:23Z
publishDate 2022
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:d1146268-a898-49d1-8a7b-a441b67e31d02022-09-29T10:02:29ZGeographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicityJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d1146268-a898-49d1-8a7b-a441b67e31d0EnglishSymplectic ElementsPublic Library of Science2022Park, J-HKim, M-HSutanto, ENa, S-WKim, M-JYeom, JSNyunt, MHAbbas Elfaki, MMAbdel Hamid, MMCha, SHAlemu, SGSriprawat, KAnstey, NMGrigg, MJBarber, BEWilliam, TGao, QLiu, YPearson, RDPrice, RNNosten, FYoon, S-INo, JHHan, E-TAuburn, SRussell, BHan, J<p><em>Plasmodium vivax</em>&nbsp;is the most widespread cause of human malaria. Recent reports of drug resistant vivax malaria and the challenge of eradicating the dormant liver forms increase the importance of vaccine development against this relapsing disease.&nbsp;<em>P</em>.&nbsp;<em>vivax</em>&nbsp;reticulocyte binding protein 1a (PvRBP1a) is a potential vaccine candidate, which is involved in red cell tropism, a crucial step in the merozoite invasion of host reticulocytes. As part of the initial evaluation of the PvRBP1a vaccine candidate, we investigated its genetic diversity and antigenicity using geographically diverse clinical isolates. We analysed&nbsp;<em>pvrbp1a</em>&nbsp;genetic polymorphisms using 202 vivax clinical isolates from six countries.&nbsp;<em>Pvrbp1a</em>&nbsp;was separated into six regions based on specific domain features, sequence conserved/polymorphic regions, and the reticulocyte binding like (RBL) domains. In the fragmented gene sequence analysis, PvRBP1a region II (RII) and RIII (head and tail structure homolog, 152&ndash;625 aa.) showed extensive polymorphism caused by random point mutations. The haplotype network of these polymorphic regions was classified into three clusters that converged to independent populations. Antigenicity screening was performed using recombinant proteins PvRBP1a-N (157&ndash;560 aa.) and PvRBP1a-C (606&ndash;962 aa.), which contained head and tail structure region and sequence conserved region, respectively. Sensitivity against PvRBP1a-N (46.7%) was higher than PvRBP1a-C (17.8%). PvRBP1a-N was reported as a reticulocyte binding domain and this study identified a linear epitope with moderate antigenicity, thus an attractive domain for merozoite invasion-blocking vaccine development. However, our study highlights that a global PvRBP1a-based vaccine design needs to overcome several difficulties due to three distinct genotypes and low antigenicity levels.</p>
spellingShingle Park, J-H
Kim, M-H
Sutanto, E
Na, S-W
Kim, M-J
Yeom, JS
Nyunt, MH
Abbas Elfaki, MM
Abdel Hamid, MM
Cha, SH
Alemu, SG
Sriprawat, K
Anstey, NM
Grigg, MJ
Barber, BE
William, T
Gao, Q
Liu, Y
Pearson, RD
Price, RN
Nosten, F
Yoon, S-I
No, JH
Han, E-T
Auburn, S
Russell, B
Han, J
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
title Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
title_full Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
title_fullStr Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
title_full_unstemmed Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
title_short Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
title_sort geographical distribution and genetic diversity of plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicity
work_keys_str_mv AT parkjh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT kimmh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT sutantoe geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT nasw geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT kimmj geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT yeomjs geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT nyuntmh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT abbaselfakimm geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT abdelhamidmm geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT chash geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT alemusg geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT sriprawatk geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT ansteynm geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT griggmj geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT barberbe geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT williamt geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT gaoq geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT liuy geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT pearsonrd geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT pricern geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT nostenf geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT yoonsi geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT nojh geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT hanet geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT auburns geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT russellb geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity
AT hanj geographicaldistributionandgeneticdiversityofplasmodiumvivaxreticulocytebindingprotein1acorrelateswithpatientantigenicity